Adenoma de hipófise ou de pituitária é um tumor não-maligno que ocorre na hipófise. se estendem do hipotálamo, com o qual está conectado pelo talo hipofisário. Assim, adenomas não-secretores podem ser de células nulas ou adenomas adenomas lactotróficos (prolactinomas), secreta prolactina · acidofílico. This page includes the following topics and synonyms: Pituitary Adenoma, Pituitary Pituitario Secretor de PRL, Adenoma Pituitario Secretor de Prolactina . de GH, Adenoma Somatotrófico, Adenoma Hipofisário Secretor de GH, Adenoma. En el caso de los adenomas hipofisarios, (de cualquiera de los cinco tipos celulares posibles), rara vez son malignos, GH: adenoma secretor de hormona de.

Author: Dibar Maurisar
Country: Armenia
Language: English (Spanish)
Genre: Environment
Published (Last): 23 January 2017
Pages: 36
PDF File Size: 2.16 Mb
ePub File Size: 7.69 Mb
ISBN: 471-8-57442-309-9
Downloads: 65008
Price: Free* [*Free Regsitration Required]
Uploader: Mojora

All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Doses entre e 1. Ann Ital Med Int ; Miller JW, Crapo L. Long-term treatment with dopamine agonist CV of patients with clinically non-functioning, gonadotroph, or a-subunit secreting pituitary adenoma.

They produce symptoms of a mass-related lesion. Clin Endocrinol Oxf ; Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume and hormone response to octreotide therapy and do not correlate with tumor histology.


Adenoma de hipófise – Wikipédia, a enciclopédia livre

Your pituitary gland is a pea-sized gland prolacyina the base of your brain. Effect of chronic bromocriptine administration on tumor size in patients with “nonsecreting” pituitary adenomas. Definition NCI A hormone producing or non-producing pituitary gland adenoma or carcinoma, not associated with a hormonal syndrome.

Br Med J ;2: Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.

Thus, these drugs should be considered particularly for patients who are poor candidates for surgery or in whom surgery and radiotherapy have failed to control the prolatina.

Management of non-functioning pituitary adenomas. Management of extrasellar pituitary tumours with bromocriptine treatment: Search Advanced search allows to you precisely focus your query. Lanreotide and cabergoline pre-operative therapy in non-functioning macroadenomas without visual impairement.

Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. How to cite this article.

Endocrinol Metab Clin North Am ; Metyrapone, mitotane and ketoconazole preferable for causing less adenomq are the most effective drugs for the control of hypercortisolism but none of them surpasses the efficacy of transsphenoidal surgery TSA. Pituitary Adenomas; Cushing’s disease; Treatment; Inhibitors of adrenal steroidogenesis; Somatostatin analogues; Dopamine agonists.


adenoma hipofisario secretor de prolactina pdf – PDF Files

Ann Endocrinol Paris ; Extensive personal experience – Surgical management of pituitary tumors. Endocrine aspects of male sexual dysfunctions.

Rapid improvement of visual fields following bromocriptine treatment of patients with non-functioning pituitary adenomas. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. Definition NCI An adenoma of the anterior lobe of the pituitary gland that produces prolactin.

Dopamine agonists and pituitary tumour shrinkage. Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. Restoration of ovarian cyclicity and ovulation induction in hypopituitary women.

J Clin Endocrinol Metab. Endocr Rev ;6: Definition NCI A rare adenoma of the anterior lobe of the pituitary gland that produces thyrotropin.


Definition NCI An adenoma of the pituitary gland that produces corticotropin. Medical therapy for Cushing’s disease. A rare adenoma of the anterior lobe of the pituitary gland that produces thyrotropin. Endocrine Rev ;